PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 655 of 764

Advanced search
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Polyomavirus JC investigation request form E13

Form (E13): polyomavirus investigation.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US biotech index hits record high, Danske Bank cites several drivers

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Dizal (Jiangsu) Pharmaceutical Co. Ltd. Class A – SSE:688192

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Parvovirus B19 referral form

Form (E9): requesting serology and PCR tests.

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Varicella zoster virus referral form

Form (E11) for testing of varicella zoster virus.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Shandong Xinhua Pharmaceutical Company Limited Class H – LSX:A0M4YV

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

HHV-6 and HHV-7 referral form

Form (E18): Human herpesvirus 6 (HHV-6) integration studies and human herpesvirus 7 (HHV-7) detectio...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CNX and Legacy set July US relaunch for Ethyol

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

2 nationwide recalls you’ll want to check today

Rolling OutOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Otsuka posts positive Phase IIIb data for novel ADHD therapy

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 2 · Trade media

How iBio aims to stand out in obesity by targeting ‘both sides of the equation’ for antibody discovery

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Debt to equity ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmaceutical Technology

Pharmaceutical TechnologyOriginal source
🇿🇦Researchsu.ac.zaTier 3 · Secondary coverage

Seven days of gambling could wipe out a year of national student funding

Stellenbosch UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Explosion and fire at pharmaceutical facility in New York State

HazardExOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Long term debt to total assets ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Debt to assets ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Rallies On Pipeline Optimism, Is The Stock Already Pricey?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Pharmagreen Biotech Inc. – OTC:PHBI

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA ratio of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Operating margin % of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Net margin % of Gin Hwa Biotech, Inc. – TPEX:7806

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UK BioTech Thalia Therapeutics raises €3.1 million and acquires Sanmirna Therapeutics

EU-StartupsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Internal EU document: Biotech Act has only limited impact

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New ASPE Report Finds U.S. Revenue Fuels Disproportionate Share of Pharmaceutical R&D Incentives

NAVLIN DAILYOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Clostridioides difficile ribotyping network (CDRN) report

Trends in ribotypes of Clostridioides difficile (C. difficile) and research into the increased frequ...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: business appointment rules advice, January to March 2026

Summaries of advice given under the business appointment rules to applicants at SCS2 and SCS1 level...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Weekly all-cause mortality surveillance: week ending 28 June 2026

How the actual number of deaths in England compare with expected numbers for each week.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

“Women should be valued and protected in pregnancy” – Heartbeat weighs in on abortion pill case

Pregnancy Help NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Expired gear, missing records: 2 Mumbai, Thane blood centres shut over safety lapses

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ProQR validates RNA editing platform and raises $59.2m

European Biotechnology MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Assenagon Asset Management S.A. Decreases Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GCP Breakdown at King’s College Hospital Just Clouded the Most Promising Parkinson’s Trial in Years

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Unapproved Retatrutide Use Challenges Clinicians

MedscapeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Teva Pharmaceutical Industries Limited Sponsored ADR – FWB:TEV

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Shares Experience Studying Adjunctive Psychedelic For Major Depressive Disorder

Clinical LeaderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Invests $1.4 Million In Lycia Series D Financing

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 Clinical-Stage Biotech Stocks Worth Watching In Parkinson's Research

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea's chip fund makes first biotech bet, backing LigaChem with $323 million

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea's chip fund makes first biotech bet, backing LigaChem with $323 million

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FIRST AID: Biotech Act deal by Christmas?

EuractivOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cereno Scientific Reports EAP Analyses with CS1 in PAH: Majority of Completing Patients Achieved Stable or Improved Clinical Status over 12 Months

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lupin Gets Tentative US FDA Nod for Enzalutamide Tablets

WhalesbookOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lupin gets tentative US FDA approval for generic prostate cancer drug

Business StandardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Does the FDA's Priority Review Mean for Savara's MOLBREEVI

Kavout | AIOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

First Aid Kit Recall: North American Rescue Issues Correction for First Aid Kits Containing TRUE METRIX Devices

North American Rescue is correcting first aid kits that contain blood glucose monitors affected by T...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How GLP-1 Demand Is Reshaping Pharma Manufacturing Strategy

Powder & Bulk SolidsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Does Breakthrough Therapy Designation Mean for Relay Therapeutics

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Drug maker sues to halt implementation of Arkansas' new pharmaceutical distribution law

Texarkana GazetteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals (RCE) Investor presentation Summary

QuartrOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce raises A$4M as it advances anti-infective trials and commercial licensing plans; another $4M to come in SPP

Proactive financial newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hong Kong biotech delegation makes strong US showing at BIO 2026

China Daily - Global EditionOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea

데일리팜Original source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

MSNOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source
🇯🇵Industrysanten.comTier 1 · Company source

Santen Obtains Marketing Approval in the Philippines for STN1012700 (Ryjusea 0.25mg/mL Ophthalmic Solution), an Ophthalmic Solution to Slow the Progression of Myopia — First Approval in Santen’s Asia Business Region

Santen PharmaceuticalOriginal source
🇿🇦Researchnews.uct.ac.zaTier 2 · Direct publisher

UCT hosts global conference on digital mental health

University of Cape TownOriginal source